Healthcare Services

D Dimer Testing Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The D Dimer Testing Market Over The 2026–2030 Period?

The d dimer testing market size has shown substantial growth in recent years. It is anticipated to increase from $1.54 billion in 2025 to $1.62 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.2%. Historically, this expansion can be linked to the significant occurrence of thrombotic disorders, widespread hospital-based laboratory testing, a reliance on elisa methods, the demand for emergency diagnostics, and limited access to rapid testing solutions.

The d dimer testing market size is poised for robust expansion in the coming years. It is forecast to achieve a value of $2.02 billion by 2030, progressing at a compound annual growth rate (CAGR) of 5.7%. This expected growth during the forecast period is attributable to factors such as the rise of point-of-care diagnostics, the increasing burden of cardiovascular diseases, advancements in immunoassay technologies, the demand for faster turnaround times, and the spread of decentralized testing. Prominent trends for the forecast period involve the growing acceptance of point-of-care testing, its expanded application in emergency diagnostics, the wider deployment of automated laboratory analyzers, the proliferation of rapid testing kits, and its incorporation into clinical decision protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12341&type=smp

Which Major Factors Are Driving The Expansion Of The D Dimer Testing Market?

The future expansion of the d-dimer testing market is anticipated due to the rising occurrence of cancer. Cancer describes a group of illnesses where abnormal cells multiply uncontrollably within almost any body organ or tissue, exceeding their normal limits, and potentially spreading or invading nearby areas. D-dimer testing serves a key role in assisting the diagnosis, monitoring, and treatment of cancer patients, as well as evaluating the likelihood of blood clot formation by tracking thrombotic events across diverse clinical environments. For example, in May 2025, the National Cancer Institute (NCI), a US-based government agency dedicated to cancer research and education, projected that in 2025 approximately 2,041,910 new cancer cases would be diagnosed in the United States, with 618,120 fatalities from the illness. Among males, prostate, lung, and colorectal cancers are forecast to comprise around 48% of all new cancer diagnoses, while among females, breast, lung, and colorectal cancers will constitute approximately 51% of all new cases. Furthermore, an estimated 14,690 children and adolescents aged 0 to 19 are expected to be diagnosed with cancer in 2025, with 1,650 projected to succumb to the disease. Consequently, the growing prevalence of cancer is fueling the expansion of the d-dimer testing market.

How Is The D Dimer Testing Market Segmented Across Key Categories?

The d dimer testing market covered in this report is segmented –

1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests

2) By Product: Analyzers, Reagents And Consumables

3) By Method: Enzyme-Linked Immunosorbent Assay (ELISA), Latex-Enhanced Immuno-Turbidimetric Assays, Fluorescence Immunoassays, Other Testing Methods

4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Applications

5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-Users

Subsegments:

1) By Clinical Laboratory Tests: Enzyme-Linked Immunosorbent Assay (Elisa), Chemiluminescent Immunoassay (CLIA), Latex Agglutination Assays

2) By Point-Of-Care Tests: Rapid Test Kits, Portable Testing Devices, Lateral Flow Assays

How Are Trends Shaping The Direction Of The D Dimer Testing Market?

Leading firms within the d-dimer testing market are innovating products, including the D-dimer test kit, to enhance the precision and rapidity of blood clot disorder diagnosis. A D-dimer test kit serves as a medical diagnostic instrument designed to quantify D-dimer levels, a specific fibrin degradation product found in the blood. This measurement assists in evaluating the existence of blood clots and associated conditions such as deep vein thrombosis, pulmonary embolism, or disseminated intravascular coagulation. For instance, Bionote Inc., a medical equipment manufacturer located in South Korea, unveiled its Vcheck D-dimer 5Tests/Kit in July 2024. This new D-dimer 5-Test Kit, developed for Vcheck immunodiagnostic equipment, is tailored for use in veterinary clinics, facilitating the diagnosis of conditions like thrombosis and DIC, and proving particularly suitable for smaller clinics managing fewer emergency situations.

Who Are The Dominant Players Shaping The D Dimer Testing Market Landscape?

Major companies operating in the d dimer testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation

Read the full d dimer testing market report here:

https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

Which Region Currently Holds The Largest Share Of The D Dimer Testing Market?

North America was the largest region in the D dimer testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the d dimer testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored D Dimer Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12341&type=smp

Browse Through More Reports Similar to the Global D Dimer Testing Market 2026, By The Business Research Company

Dimer Acid Global Market Report

https://www.thebusinessresearchcompany.com/report/dimer-acid-global-market-report

Dimethyl Ether Global Market Report

https://www.thebusinessresearchcompany.com/report/dimethyl-ether-global-market-report

Medical Device Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795